CIMZIA
$1,499.00 – $1,999.00
Additional information
| Language | English, Non-English |
|---|
Cimzia is a brand-name prescription medication. It’s used to reduce inflammation (swelling) associated with several long-term conditions. Cimzia is FDA-approved in adults for these conditions:
- Plaque psoriasis (the most common form of the skin condition psoriasis). Cimzia is used to treat moderate to severe plaque psoriasis that could benefit from systemic treatment (treatment that affects the whole body) or phototherapy (light treatment that treats or affects just the skin).
- Crohn’s disease (a type of inflammatory bowel disease). Cimzia is used to lessen signs and symptoms of moderate to severe Crohn’s disease that’s active (causing symptoms). It’s used when other treatments haven’t helped enough.
- Rheumatoid arthritis (a disease that causes joint swelling and damage). Cimzia is used to treat moderate to severe rheumatoid arthritis that’s active.
- Psoriatic arthritis (a type of joint swelling that can sometimes happen in people with psoriasis). Cimzia is used to treat psoriatic arthritis that’s active.
- Ankylosing spondylitis (a kind of joint swelling that affects the spine). Cimzia is used to treat ankylosing spondylitis that’s active.
- Non-radiographic axial spondyloarthritis (a type of joint swelling in the spine or pelvis that causes pain and stiffness but that can’t be seen on an X-ray).
Cimzia is used to treat active non-radiographic axial spondyloarthritis in people who have signs of inflammation in blood tests or MRI scans (pictures of the inside of your body using magnets and radio waves).
Cimzia is a biologic drug (a medication made using living cells). It’s a type of drug called a tumor necrosis factor (TNF) blocker.
Cimzia is given by subcutaneous injection (under the skin). The injection comes in two forms: as a single-dose vial and a single-dose prefilled syringe.
